Overlap lamivudine treatment in patients with chronic hepatitis B receiving adefovir for lamivudine-resistant viral mutants
- 23 March 2006
- journal article
- clinical trial
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 13 (6) , 387-395
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Comparison of Adefovir and Tenofovir in the Treatment of Lamivudine–Resistant Hepatitis B Virus InfectionHepatology, 2004
- Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysisJournal of Hepatology, 2004
- Combinations of Adefovir with Nucleoside Analogs Produce Additive Antiviral Effects against Hepatitis B Virus In VitroAntimicrobial Agents and Chemotherapy, 2004
- Chronic hepatitis B: Update of recommendations† ‡Hepatology, 2004
- Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B1Gastroenterology, 2004
- 242 Molecular modelling and functional studies of adefovir resistant mutations in the hepatitis B virus polymerase selected during therapyHepatology, 2003
- Hepatitis B virus variants in patients receiving lamivudine treatment with breakthrough hepatitis evaluated by serial viral loads and full-length viral sequencesHepatology, 2001
- Hepatitis B e antigen seroconversion after lamivudine therapy is not durable in patients with chronic hepatitis B in KoreaHepatology, 2000
- Lamivudine as Initial Treatment for Chronic Hepatitis B in the United StatesNew England Journal of Medicine, 1999
- From Hepatitis to Hepatoma: Lessons from Type B Viral HepatitisScience, 1993